ConductScience.org, home

Paper40211368

Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer.

Zhang M and 1 other. Exp Hematol Oncol, 2025. Cited by 209 papers, by iCite.

Cite this record

ConductScience Library. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Papers, record 40211368. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40211368

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer.
PubMed
Journal
Exp Hematol Oncol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
209
iCite
Relative citation ratio, by iCite
57.16, provisional
iCite
Revised in PubMed
2025-04-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang MMeiling
2Zhang BBin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References204

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136746510Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors.J Immunother Cancer2023https://conductscience.org/library/papers/36746510PubMed
219931152Matrix crosslinking forces tumor progression by enhancing integrin signaling.Cell2009https://conductscience.org/library/papers/19931152PubMed
336684109Pin1/YAP pathway mediates matrix stiffness-induced epithelial-mesenchymal transition driving cervical cancer metastasis via a non-Hippo mechanism.Bioeng Transl Med2023https://conductscience.org/library/papers/36684109PubMed
434297718Machine learning reveals mesenchymal breast carcinoma cell adaptation in response to matrix stiffness.PLoS Comput Biol2021https://conductscience.org/library/papers/34297718PubMed
534106045Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment.Elife2021https://conductscience.org/library/papers/34106045PubMed
621744247Matrix metalloproteinases in tumorigenesis: an evolving paradigm.Cell Mol Life Sci2011https://conductscience.org/library/papers/21744247PubMed
724851253[Paul Bornstein (1934–2013), a pioneer of matrix biology and pathology].Pathol Biol (Paris)2014https://conductscience.org/library/papers/24851253PubMed
831319162Revisiting the hallmarks of cancer: The role of hyaluronan.Semin Cancer Biol2020https://conductscience.org/library/papers/31319162PubMed
935659296Characteristics of the cancer stem cell niche and therapeutic strategies.Stem Cell Res Ther2022https://conductscience.org/library/papers/35659296PubMed
1022053288Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look.Cancer Discov2011https://conductscience.org/library/papers/22053288PubMed
1123649148Positive and negative influence of the matrix architecture on antitumor immune surveillance.Cell Mol Life Sci2013https://conductscience.org/library/papers/23649148PubMed
1225893917Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway.Nat Cell Biol2015https://conductscience.org/library/papers/25893917PubMed
1333513979Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours.Cancers (Basel)2021https://conductscience.org/library/papers/33513979PubMed
1425376097Is there new hope for therapeutic matrix metalloproteinase inhibition?Nat Rev Drug Discov2014https://conductscience.org/library/papers/25376097PubMed
1533287873Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer.J Hematol Oncol2020https://conductscience.org/library/papers/33287873PubMed
1633008805Soft Microenvironments Induce Chemoresistance by Increasing Autophagy Downstream of Integrin-Linked Kinase.Cancer Res2020https://conductscience.org/library/papers/33008805PubMed
1721240262The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.Nat Med2011https://conductscience.org/library/papers/21240262PubMed
1831324706Collagen cross-linking mediated by lysyl hydroxylase 2: an enzymatic battlefield to combat fibrosis.Essays Biochem2019https://conductscience.org/library/papers/31324706PubMed
1932483419CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.Theranostics2020https://conductscience.org/library/papers/32483419PubMed
2026258633Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth.Nat Cell Biol2015https://conductscience.org/library/papers/26258633PubMed

See all 204 referencesDownload CSV of references

Cited by178

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 209 citations.

PMIDTitleJournalYearIn PapersSource
42983536Metabolic-extracellular matrix crosstalk in hepatocellular carcinoma: mechanisms and targeted intervention.Cell Commun Signal2026https://conductscience.org/library/papers/42983536PubMed
42978946Mechanochemical coupling in lung cancer: how tissue tension drives genomic instability and malignant progression.Front Cell Dev Biol2026https://conductscience.org/library/papers/42978946PubMed
42958443HER2 in solid tumors: microenvironment features and multifaceted advances from mechanisms to clinical translation.Exp Hematol Oncol2026https://conductscience.org/library/papers/42958443PubMed
42955533QSOX1 as a mediator of tumor-fibroblast crosstalk and a modulator of pulmonary tumor burden in lung adenocarcinoma.Mol Cell Biochem2026https://conductscience.org/library/papers/42955533PubMed
42941901Metabolic Dysfunction and T-Cell Exhaustion in Colorectal Cancer: Mechanisms, Microenvironment Remodeling, and Therapeutic Opportunities.Int J Mol Sci2026https://conductscience.org/library/papers/42941901PubMed
42910293ECM stiffness inhibits ferroptosis to promote HCC progression via the FOXA1-CDON-HMGB1/p53 pathway.Int J Biol Sci2026https://conductscience.org/library/papers/42910293PubMed
42903636Impact of aging on the tumor microenvironment in oral cancer: Mechanisms and therapeutic perspectives.J Taibah Univ Med Sci2026https://conductscience.org/library/papers/42903636PubMed
42898419Hydrogel-based smart bioinks for 3D bioprinting: design strategies and applications in brain tissue engineering and tumor microenvironment modelling.Bioimpacts2026https://conductscience.org/library/papers/42898419PubMed
42888420Niches in cancer: from primary tumors to metastatic disease.J Hematol Oncol2026https://conductscience.org/library/papers/42888420PubMed
42859163Metabolic reprogramming in cancer-associated fibroblasts: orchestrating the tumor immune microenvironment and response to immune checkpoint blockade.Exp Hematol Oncol2026https://conductscience.org/library/papers/42859163PubMed
42832574Exploring the key genes of colorectal "adenoma-cancer" based on graph transformer.PLoS One2026https://conductscience.org/library/papers/42832574PubMed
42828102Engineered probiotics couple photothermal cuproptosis with biomechanical disruption and immune activation.Bioact Mater2027https://conductscience.org/library/papers/42828102PubMed
42798839Identification and assessment of FN1, MET, KRT19 and CLDN1 as key dysregulated genes in papillary thyroid cancer through transcriptomic profiling and expression analysis.Oncol Lett2026https://conductscience.org/library/papers/42798839PubMed
42793270Current Perspectives on 2D and 3D Cell Culture Models in Cancer Research: Molecular Determinants of Tumor Biology and Therapeutic Response.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42793270PubMed
42792643An L1CAM-Positive Fibroblast-Associated Stromal State Is Associated with Reduced T/NK Cytotoxicity Features in Colorectal Cancer.Biomedicines2026https://conductscience.org/library/papers/42792643PubMed
42787254Beyond Structure: The Dynamic Role of the Extracellular Matrix Components in Immune Evasion.Cancer Commun (Lond)2026https://conductscience.org/library/papers/42787254PubMed
42782738Biomarker-Driven Strategies for Stromal Reprogramming in Pancreatic Ductal Adenocarcinoma.Cells2026https://conductscience.org/library/papers/42782738PubMed
42766730Fibroblast-associated TPM2 links cell-matrix remodeling to EMT-Notch signaling and gemcitabine resistance in intrahepatic cholangiocarcinoma.Cancer Biol Ther2026https://conductscience.org/library/papers/42766730PubMed
42749970LOXL4: a key regulatory factor at the intersection of fibrosis and tumor progression.Hum Cell2026https://conductscience.org/library/papers/42749970PubMed
42738717Nano-Metal Hydrogen Therapy Targeting Immune Cells Drives Synergistic Anti-Tumor Effects.Molecules2026https://conductscience.org/library/papers/42738717PubMed

See all 178 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40211368

GET https://conductscience.org/api/papers/v1/40211368/references?page=2